Results 131 to 140 of about 74,341 (223)

Imatinib Resistance in Chronic Myeloid Leukemia Is Associated with Distinct Metabolic, Oxidative, and Autophagic Adaptations in K562-Derived Cell Sublines. [PDF]

Biomedicines
Rachid E, Lahmouad M, Bellemrrabet R, Aboussaleh Y, Amahdar L, Abboussi O.   +5 more
europepmc   +1 more source

Generic versus branded imatinib in frontline chronic myeloid leukemia: A systematic review and meta-analysis. [PDF]

Hemasphere
Biswas S, Srivastava Y, Tummala N, Hamadttu A.   +3 more
europepmc   +1 more source

The role of tyrosine kinase inhibitors as a post-hematopoietic stem cell transplant continuation therapy for pediatric acute leukemia: a systematic review. [PDF]

Cancer Chemother Pharmacol
Avineni M, Habo YK, Habo NK, Elsayed AAR, Basson MD.   +4 more
europepmc   +1 more source

Sequential Philadelphia-Positive Pre-B Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia With Distinct BCR::ABL1 Fusion Transcripts. [PDF]

Cancer Rep (Hoboken)
Latifi A, Yousefian S.
europepmc   +1 more source

Imatinib Mesylate and Sirolimus Inhibit Vascular Fibroproliferative Remodeling in Pulmonary Vein Stenosis. [PDF]

Children (Basel)
Gaal J, Doettl SC, Saraci K, Zajac C, von Mueffling A, Hammer PE, von Piechowski M, Gebert V, Caracioni AM, Diaz-Gil D, Weixler V, Del Nido PJ, Jenkins K, Friehs I.   +13 more
europepmc   +1 more source

Nilotinib revisited in GIST: salvage use in patients with severe imatinib toxicity. [PDF]

Oncologist
Falkenhorst J, Hohenberger P, Mancino G, Scrima A, Menge F, Fletcher BS, Reiff C, Lange V, Hamacher R, Bertram S, Rau FM, Zaun Y, Kaths M, Treckmann J, Jakob J, Mühlenberg T, Grunewald S, Krzeciesa D, Rauh D, Bauer S.   +19 more
europepmc   +1 more source

Identifying actionable targets: predicting imatinib nonadherence in patients with gastrointestinal stromal tumors. [PDF]

J Gastrointest Oncol
Janczewski LM.
europepmc   +1 more source

Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions. [PDF]

ESMO Gastrointest Oncol
Scheuble AM, Lordick F, Maki RG.
europepmc   +1 more source

Therapeutic drug-monitoring-guided desensitization for severe imatinib-associated rash. [PDF]

J Gastrointest Oncol
Dy PS, Lou E.
europepmc   +1 more source

The prognosis of patients with gastrointestinal stromal tumors harboring the KIT exon 11 mutation: a retrospective cohort study. [PDF]

J Gastrointest Oncol
Shou C, Yang W, Wang X, Zhang Q, Yu J, Liang T.   +5 more
europepmc   +1 more source